
Texas Immunology, Inc.
Free shipping on orders over $99 · 30-day returns
V-TREND BETA-HCG DRY-SPOT TEST is an FDA 510(k)-cleared medical device (K875262) manufactured by Texas Immunology, Inc.. This device is classified under the Clinical Chemistry specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on February 1, 1988. Regulation: 8.